1. Home
  2. CSBR vs IGI Comparison

CSBR vs IGI Comparison

Compare CSBR & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • IGI
  • Stock Information
  • Founded
  • CSBR 1985
  • IGI 2009
  • Country
  • CSBR United States
  • IGI United States
  • Employees
  • CSBR N/A
  • IGI N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • IGI Investment Managers
  • Sector
  • CSBR Health Care
  • IGI Finance
  • Exchange
  • CSBR Nasdaq
  • IGI Nasdaq
  • Market Cap
  • CSBR 113.0M
  • IGI 98.2M
  • IPO Year
  • CSBR 1986
  • IGI N/A
  • Fundamental
  • Price
  • CSBR $8.24
  • IGI $16.32
  • Analyst Decision
  • CSBR Strong Buy
  • IGI
  • Analyst Count
  • CSBR 1
  • IGI 0
  • Target Price
  • CSBR $12.00
  • IGI N/A
  • AVG Volume (30 Days)
  • CSBR 38.4K
  • IGI 33.9K
  • Earning Date
  • CSBR 07-17-2025
  • IGI 01-01-0001
  • Dividend Yield
  • CSBR N/A
  • IGI 4.79%
  • EPS Growth
  • CSBR N/A
  • IGI N/A
  • EPS
  • CSBR 0.46
  • IGI N/A
  • Revenue
  • CSBR $58,591,000.00
  • IGI N/A
  • Revenue This Year
  • CSBR $15.11
  • IGI N/A
  • Revenue Next Year
  • CSBR $7.80
  • IGI N/A
  • P/E Ratio
  • CSBR $17.82
  • IGI N/A
  • Revenue Growth
  • CSBR 19.03
  • IGI N/A
  • 52 Week Low
  • CSBR $3.60
  • IGI $15.13
  • 52 Week High
  • CSBR $11.99
  • IGI $17.79
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 69.99
  • IGI 48.31
  • Support Level
  • CSBR $6.27
  • IGI $16.18
  • Resistance Level
  • CSBR $8.58
  • IGI $16.45
  • Average True Range (ATR)
  • CSBR 0.64
  • IGI 0.13
  • MACD
  • CSBR 0.28
  • IGI -0.00
  • Stochastic Oscillator
  • CSBR 96.63
  • IGI 45.16

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

Share on Social Networks: